Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$0.07.

  • Eton Pharmaceuticals' EPS (Basic) fell 45000.0% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.26, marking a year-over-year decrease of 1818.18%. This contributed to the annual value of -$0.15 for FY2024, which is 26908.55% down from last year.
  • Eton Pharmaceuticals' EPS (Basic) amounted to -$0.07 in Q3 2025, which was down 45000.0% from -$0.1 recorded in Q2 2025.
  • Eton Pharmaceuticals' EPS (Basic)'s 5-year high stood at $0.21 during Q1 2021, with a 5-year trough of -$210.0 in Q1 2022.
  • In the last 5 years, Eton Pharmaceuticals' EPS (Basic) had a median value of -$0.06 in 2022 and averaged -$11.09.
  • In the last 5 years, Eton Pharmaceuticals' EPS (Basic) tumbled by 10010000.0% in 2022 and then soared by 39028.75% in 2023.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' EPS (Basic) stood at $0.04 in 2021, then dropped by 2.96% to $0.04 in 2022, then tumbled by 325.0% to -$0.09 in 2023, then soared by 74.34% to -$0.02 in 2024, then crashed by 203.12% to -$0.07 in 2025.
  • Its last three reported values are -$0.07 in Q3 2025, -$0.1 for Q2 2025, and -$0.06 during Q1 2025.